[HTML][HTML] Human disease models in drug development

A Loewa, JJ Feng, S Hedtrich - Nature reviews bioengineering, 2023 - nature.com
Biomedical research is undergoing a paradigm shift towards approaches centred on human
disease models owing to the notoriously high failure rates of the current drug development …

[HTML][HTML] Microfluidic organ-on-a-chip: a guide to biomaterial choice and fabrication

UMN Cao, Y Zhang, J Chen, D Sayson, S Pillai… - International journal of …, 2023 - mdpi.com
Organ-on-A-chip (OoAC) devices are miniaturized, functional, in vitro constructs that aim to
recapitulate the in vivo physiology of an organ using different cell types and extracellular …

Organs-on-a-chip: a union of tissue engineering and microfabrication

Y Zhao, EY Wang, FBL Lai, K Cheung, M Radisic - Trends in Biotechnology, 2023 - cell.com
We review the emergence of the new field of organ-on-a-chip (OOAC) engineering, from the
parent fields of tissue engineering and microfluidics. We place into perspective the tools and …

[HTML][HTML] Organ-on-a-chip meets artificial intelligence in drug evaluation

S Deng, C Li, J Cao, Z Cui, J Du, Z Fu, H Yang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Drug evaluation has always been an important area of research in the pharmaceutical
industry. However, animal welfare protection and other shortcomings of traditional drug …

Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes

RXZ Lu, N Rafatian, Y Zhao, KT Wagner… - Science …, 2024 - science.org
Despite tremendous progress in the development of mature heart-on-a-chip models, human
cell–based models of myocardial inflammation are lacking. Here, we bioengineered a …

[HTML][HTML] Biomimetic lung-on-a-chip to model virus infection and drug evaluation

J Tan, Q Guo, L Tian, Z Pei, D Li, M Wu, J Zhang… - European Journal of …, 2023 - Elsevier
Viral infectious diseases remain a global public health problem. The rapid and widespread
spread of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory …

[HTML][HTML] Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies

D Gustafson, M Ngai, R Wu, H Hou, AC Schoffel… - …, 2022 - thelancet.com
Background Endothelial cell (EC) activation, endotheliitis, vascular permeability, and
thrombosis have been observed in patients with severe coronavirus disease 2019 (COVID …

[HTML][HTML] Application of microfluidic technologies on COVID-19 diagnosis and drug discovery

Z Lin, Z Zou, Z Pu, M Wu, Y Zhang - Acta Pharmaceutica Sinica B, 2023 - Elsevier
The ongoing coronavirus disease 2019 (COVID-19) pandemic has boosted the
development of antiviral research. Microfluidic technologies offer powerful platforms for …

[HTML][HTML] Organ-on-a-chip models for elucidating the cellular biology of infectious diseases

F Yokoi, S Deguchi, K Takayama - … et Biophysica Acta (BBA)-Molecular Cell …, 2023 - Elsevier
Infectious diseases are caused by the invasion of pathogens into a host. To explore the
mechanisms of pathogen infections and cellular responses, human models that can …

[HTML][HTML] Integration of immune cells in organs-on-chips: a tutorial

L Van Os, B Engelhardt, OT Guenat - Frontiers in Bioengineering and …, 2023 - frontiersin.org
Viral and bacterial infections continue to pose significant challenges for numerous
individuals globally. To develop novel therapies to combat infections, more insight into the …